August 10, 2012 — We are pleased to announce that HeatFlow Technologies has been chosen to present at BIO Investor Forum 2012, which will take place in San Francisco on October 9-10. The conference is sponsored by BIO, the nation's most prominent biotechnology industry group. The purpose of the national investor forum is "to explore investment trends and opportunities in life sciences, with a focus on venture-stage growth and emerging public companies as well as those poised to join the growth ‘watch list' in 2013." More information, including our presentation date and time, will be posted soon on the conference website: www.bio.org/events/conferences/about-bio-investor-forum.
June 1, 2012 — HeatFlow Technologies has been accepted as a presenter at Life Science Innovation Northwest, the Northwest's premier biotechnology and biomedical investor conference. LSINW will be held in Seattle at the Washington State Convention Center on July 11 and 12. Our company's presentation will be on the morning of July 12. Please join us! Information about the conference is available from the Washington Biotechnology & Biomedical Association (www.washbio.org).
April 12, 2012 — The patent for our HF-PCR™ technology (US Pat. No. 8,153,374) has issued. A link to the full patent text is available on our Technology page.
February 6, 2012 — The United States Patent & Trademark Office issued a notice of allowance for our Heat Flow Polymerase Chain Reaction Methods patent application. The patent, which covers our core technology, will be issued in late March or early April 2012.